| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.99B | 18.06B | 17.44B | 16.54B | 16.42B | 15.99B |
| Gross Profit | 6.16B | 6.20B | 6.49B | 5.98B | 6.13B | 6.21B |
| EBITDA | 1.74B | 2.34B | 2.35B | 2.25B | 2.38B | 2.35B |
| Net Income | 1.06B | 1.11B | 1.29B | 1.22B | 1.35B | 1.37B |
Balance Sheet | ||||||
| Total Assets | 28.14B | 29.37B | 29.04B | 27.40B | 26.01B | 25.03B |
| Cash, Cash Equivalents and Short-Term Investments | 5.66B | 5.06B | 4.11B | 6.80B | 7.42B | 6.64B |
| Total Debt | 1.43B | 1.20B | 454.00M | 423.00M | 444.00M | 440.00M |
| Total Liabilities | 6.43B | 7.44B | 6.67B | 7.31B | 6.88B | 6.90B |
| Stockholders Equity | 21.70B | 21.92B | 22.37B | 20.09B | 19.12B | 18.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 448.00M | -2.31B | -231.00M | 1.15B | 1.39B |
| Operating Cash Flow | 0.00 | 1.84B | 165.00M | 307.00M | 1.49B | 1.81B |
| Investing Cash Flow | 0.00 | -596.00M | -1.73B | -374.00M | -366.00M | -451.00M |
| Financing Cash Flow | 0.00 | 266.00M | -376.00M | -553.00M | -343.00M | -482.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥107.81B | 15.13 | ― | 3.23% | 7.28% | 4.16% | |
78 Outperform | ¥844.87B | 18.06 | 11.99% | 0.65% | 8.50% | 14.06% | |
73 Outperform | ¥17.51B | 26.81 | ― | 2.59% | 1.66% | -12.21% | |
73 Outperform | ¥18.96B | 18.81 | ― | 2.93% | -1.58% | 12.24% | |
72 Outperform | ¥22.62B | 7.24 | ― | 2.84% | 8.78% | 16.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥8.97B | 16.72 | ― | 2.45% | 15.66% | -69.17% |